Related Experiment Video

Updated: Sep 16, 2026

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures
11:22

Vibratome Sectioning Mouse Retina to Prepare Photoreceptor Cultures

Published on: December 22, 2014

Progressive human cone-rod dysfunction (dystrophy)

G A Fishman

    Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology
    |July 1, 1976
    PubMed

    Insights

    This study classifies progressive cone-rod dysfunction into primary (types 1 and 2) and secondary (type 3) forms. Classification is based on electroretinogram (ERG) findings and retinal pigment epithelium defects, aiding diagnosis.

    Area of Science:

    • Ophthalmology
    • Genetics
    • Retinal Diseases

    Background:

    • Progressive cone-rod dysfunction is a group of inherited retinal diseases.
    • Accurate classification is crucial for understanding disease mechanisms and patient management.

    Purpose of the Study:

    • To classify progressive human cone-rod dysfunction into distinct subtypes.
    • To identify key diagnostic features for each subtype.

    Main Methods:

    • Classification based on electroretinogram (ERG) findings.
    • Assessment of retinal pigment epithelial (RPE) defects.
    • Identification of characteristic clinical features such as flecks.

    Main Results:

    • Primary cone-rod dysfunction (types 1 and 2) shows early ERG abnormalities.
    • Subtypes 1 and 2 are differentiated by the extent of RPE defects.
    • Secondary cone-rod dysfunction (type 3) presents with initially normal ERG and RPE flecks.

    Conclusions:

    • Progressive cone-rod dysfunction can be reliably classified into three types.
    • ERG and RPE characteristics are key for differentiating these subtypes.
    • This classification aids in diagnosing and understanding the spectrum of cone-rod dystrophies.

    More Related Videos

    Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo08:17

    Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

    Published on: September 22, 2017

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia10:41

    Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

    Published on: September 12, 2020

    Related Concept Videos

    Parkinson's Disease: Overview01:15

    Parkinson's Disease: Overview

    Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
    Huntington Disease l: Introduction01:21

    Huntington Disease l: Introduction

    Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...